Image de couverture de livre

Neurovascular de‐coupling underlies dual‐task cost across cognitive abilities

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Laura K. Fitzgibbon‐Collins, Sarah Best, Mamiko Noguchi, Corey Guest, Michael Borrie, J. Kevin Shoemaker, Jaspreet Bhangu
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Dynamic cerebral autoregulation in cognitively intact controls and in people with mild cognitive impairment
par: Laura Keiko Fitzgibbon‐Collins, et autres
Publié: (2025)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
par: Robin C. Hilsabeck, et autres
Publié: (2025)

Evaluation of racial and ethnic heterogeneity in the associations of sleep quality and sleep apnea risk with cognitive function and cognitive decline
par: Ruijia Chen, et autres
Publié: (2024)

Mapping sex differences in brain and cognition in relation to APOE ε4 and amyloid burden: A longitudinal normative modelling study
par: Sivaniya Subramaniapillai, et autres
Publié: (2026)

The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline
par: Adam J Paulsen, et autres
Publié: (2025)

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual‐level data from the A4 study of solanezumab
par: Sarah F. Ackley, et autres
Publié: (2026)

Effects of multidomain intervention on cognitive function in older adults with cognitive impairment: A multicenter, four‐arm, cluster randomized trial
par: Zhaoxue Yin, et autres
Publié: (2026)

Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia
par: Chiara Pappalettera, et autres
Publié: (2025)

Awareness and cognitive rehabilitation in Alzheimer's disease and frontotemporal dementia
par: Eric Salmon, et autres
Publié: (2024)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
par: Chao‐Yi Wu, et autres
Publié: (2025)

Vestibular‐related dizziness duration and cognitive deficits in older adults
par: Xiaobao Ma, et autres
Publié: (2025)

Directionality between cognitive function and daily physical activity patterns
par: Francesca R. Marino, et autres
Publié: (2025)

Vascular cognitive impairment and dementia drug‐development pipeline 2025
par: Ying Xu, et autres
Publié: (2026)

The interaction effect of physical activity and sleep on cognitive function in stroke
par: Ryan G. Stein, et autres
Publié: (2025)

Cost‐effectiveness of a multicomponent intervention against cognitive decline
par: Christian Brettschneider, et autres
Publié: (2025)

Translation with ongoing adaptation and improvement (ToAI) framework: A community‐informed, structured, iterative approach to culturally adapting cognitive assessment tools
par: Quyen Q. Tiet, et autres
Publié: (2025)

Brain networks modulating the relationship between white matter volume and cognition
par: Osamu Katayama, et autres
Publié: (2026)

Adaptive measurement of cognitive function based on multidimensional item response theory
par: Robert D. Gibbons, et autres
Publié: (2024)

FDA approval of Miplyffa and Aqneursa: A dual breakthrough for the treatment of Neimann–Pick disease type C
par: Mahnoor Jan, et autres
Publié: (2025)

The relationship between neurofilament light chain and depressive symptoms according to cognitive status
par: Federico Bellelli, et autres
Publié: (2025)

Rural‐Urban mild cognitive impairment comparison in West Michigan through EHR
par: Xiaodan Zhang, et autres
Publié: (2024)

Optimized 5‐HT 2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction
par: Saktimayee M. Roy, et autres
Publié: (2025)

Impact of study partner replacement in a mild cognitive impairment clinical trial
par: Lucy A. Dolmadjian, et autres
Publié: (2025)

Exploring small‐world brain connectivity in aging and its relationship with cognitive reserve
par: Chiara Pappalettera, et autres
Publié: (2026)

Developing educational materials to aid in Alzheimer's blood biomarker disclosure
par: Raymond R. Romano, et autres
Publié: (2025)

Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study
par: Davide Angioni, et autres
Publié: (2026)

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging
par: Akira Sekikawa, et autres
Publié: (2025)

Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline
par: Emilija Romic, et autres
Publié: (2026)

Activity variability: A novel physical activity metric and its association with cognitive impairment
par: Patrick T. Donahue, et autres
Publié: (2025)

Participant completion of longitudinal assessments in an online cognitive aging registry: The role of medical conditions
par: Miriam T. Ashford, et autres
Publié: (2024)

Response to: Refining the clinical interpretation of activity variability in cognitive impairment: The need for phenotypic specificity
par: Patrick T. Donahue, et autres
Publié: (2025)

Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
par: Tuyet Thao Nguyen, et autres
Publié: (2026)

The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder
par: Burak Yulug, et autres
Publié: (2024)

Hearing loss and cognitive decline: Prioritizing equity in a world in which hearing health matters
par: Carrie L. Nieman, et autres
Publié: (2024)

Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment
par: Takuya Ataka, et autres
Publié: (2024)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
par: Zhigang Xie, et autres
Publié: (2026)

Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes
par: Claire M. Erickson, et autres
Publié: (2024)

Constructive engagement in cognitive stimulation therapy groups among people with dementia: A mixed‐methods study
par: Anna Yan Zhang, et autres
Publié: (2025)

Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study
par: Norma B. Coe, et autres
Publié: (2026)

Clinical factors predicting the rate of cognitive decline in a US memory clinic: An electronic health record study
par: Yuchan Wang, et autres
Publié: (2025)